Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.

Antiviral therapy - 1 Jan 2008

Shafer Robert W, Rhee Soo-Yon, Bennett Diane E

Abstract excerpt

Programmes that monitor local, national and regional levels of transmitted HIV-1 drug resistance inform treatment guidelines and provide feedback on the success of HIV-1 treatment and prevention programmes. The World Health Organization (WHO) has established a global programme for genotypic surveillance of HIV-1 drug resistance and has recommended the adoption of a consensus definition of genotypic drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Developing Countries
Share to Epidemiologic Research Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Global Health

Share to National Health Programs

Share to Population Surveillance

Share to Terminology as Topic

Share to World Health Organization

Source

Open in PubMed Open full text

Identifiers

PMID: 18575192
PMCID: PMC4388302

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.PMID 18575192Read ↗

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.Semantic proximity Read ↗

2015 Update of the Drug Resistance Mutations in HIV-1.Semantic proximity Read ↗

European recommendations for the clinical use of HIV drug resistance testing: 2011 update.Semantic proximity Read ↗

2017 Update of the Drug Resistance Mutations in HIV-1.Semantic proximity Read ↗

HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.Semantic proximity Read ↗

Update of the drug resistance mutations in HIV-1: Fall 2006.Semantic proximity Read ↗

Update of the Drug Resistance Mutations in HIV-1: 2005.Semantic proximity Read ↗

Antiretroviral drug resistance testing.Semantic proximity Read ↗

Genotype and phenotype resistance: an overview.Semantic proximity Read ↗

Transmission and prevalence of HIV resistance among treatment-naive subjects.Semantic proximity Read ↗

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.Semantic proximity Read ↗

Update of the drug resistance mutations in HIV-1: Fall 2005.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.